Ad
related to: biogen's aduhelm- About Leqembi
Learn more about the treatment
option & how it works.
- Support & Resources
View patient support info and
downoadable resources on site.
- Getting Started
Find treatment tips to get started
with Leqembi.
- Leqembi Companion
Your online partner designed to
support you during treatment.
- Leqembi Care Partner
Explore tips for supporting
patients who are taking Leqembi.
- Sign Up For More Info
Get access to information all about
treatment & useful tips.
- About Leqembi
Search results
Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business Daily· 4 months agoBiogen's turnaround is still a "work in progress," an analyst said Tuesday as Biogen stock slumped...
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
Motley Fool· 11 months agoIt was two years ago that Biogen's (NASDAQ: BIIB) stock soared to more than $400 on news that its...
Biogen's Quarterly Report Was 'Fine' — Here's Why Shares Toppled
Investor's Business Daily· 2 years agoBiogen's second-quarter report was "fine," according to one analyst. But without an update on its...
We read through the 45-page congressional investigation into Biogen's Alzheimer's drug. Here are the...
INSIDER via Yahoo News· 1 year agoThe Biogen headquarters in Cambridge, Mass.AP Photo/Steven Senne A Congressional investigation into...
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
Motley Fool· 1 year agoIn June 2021, shares of Biogen (NASDAQ: BIIB) soared to more than $400 after the Food and Drug...
Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing report
USA TODAY via Yahoo News· 1 year agoThe Food and Drug Administration’s approval process of Alzheimer’s drug Aduhelm has been deemed...
Biogen (BIIB) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 year agoBiogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of multiple...
Is Biogen a Smart Biotech Stock to Buy Right Now?
Motley Fool· 2 years agoTens of millions of Alzheimer's disease patients were given a rare dose of good news recently when Biogen (NASDAQ: BIIB) released some encouraging...
Biogen's (BIIB) Partner Eisai Files MAA for Lecanemab in Europe
Zacks via Yahoo Finance· 1 year agoBiogen's (BIIB) partner Eisai files a marketing authorization application to the European Medicines...
Biogen's (BIIB) Lecanemab Meets Goal in Alzheimer's Study
Zacks via Yahoo Finance· 2 years agoBiogen (BIIB) and Eisai's Clarity AD study showed that treatment with lecanemab in the early stages...
Ad
related to: biogen's aduhelm
